Jones Trading Maintains Buy on WAVE Life Sciences, Raises Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Jones Trading analyst Catherine Novack maintains a Buy rating on WAVE Life Sciences (NASDAQ:WVE) and raises the price target from $12 to $16.
September 25, 2024 | 3:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jones Trading has reaffirmed its Buy rating on WAVE Life Sciences and increased the price target from $12 to $16, indicating a positive outlook.
The reaffirmation of a Buy rating and an increased price target from a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100